Strains of Yersinia wautersii should continue to be classified as the 'Korean Group' of the Yersinia pseudotuberculosis complex and not as a separate species A recent publication by Savin et al. proposes the novel species Yersinia wautersii sp. nov. originating from Yersinia pseudotuberculosis sensu stricto (Savin et al., 2014a, b) . This new taxon comprises strains known as the 'Korean group', previously revealed by multi locus sequence typing of the Y. pseudotuberculosis complex (LaukkanenNinios et al., 2011) . In making their proposal, Savin et al. (2014a) followed the rules of the Bacteriological Code that are required for a novel species to have standing in nomenclature: (1) they stated that they were proposing a novel species and used the term 'sp. nov.', (2) they designated strain 12-219N1
T as the type strain, (3) they provided a description of the novel species, (4) they provided the logic and scientific evidence for their proposal, and (5) after publishing the paper describing the novel species in a journal outside the International Journal of Systematic and Evolutionary Microbiology (IJSEM) then validated the name by having it published in Validation List 158 in IJSEM (Savin et al., 2014b) . The fifth step completed the validation process for the name of the proposed novel species and gave it standing in nomenclature under the rules of the Bacteriological Code. pseudomallei by gene loss and is considered to be a clone of the latter (Godoy et al., 2003; Holden et al., 2004) . B. mallei is the causative agent of glanders, a re-emerging zoonotic disease of horses, observed for centuries in the Western hemisphere with a high impact in the horse industry. It is highly adapted to its primary host, the horse, which is also its single reservoir. By contrast, B. pseudomallei causes a disease in humans known as melioidosis, which was first recognized in Burma in 1912 (Whitmore & Krishnaswami, 1912) . This bacterium is a soil saprophyte of tropical and subtropical wetlands which occasionally causes disease in man or animal. Melioidosis accounts for 20 % of community acquired septicaemias in northeastern Thailand but, contrary to glanders, it is not considered a disease of economic importance in animals.
Nomenclature can take into account the outstanding medical importance or traditional denomination of causative agents based on syndromes. This is the case for B. mallei and B. pseudomallei as well as for Y. pseudotuberculosis and Yersinia pestis, the latter being only a clone of Y. pseudotuberculosis with imminent pathogenicity for humans and a life cycle very different from that of the former. The correct name of Y. pestis should therefore be Y. pseudotuberculosis subsp. pestis as pointed out by Bercovier et al. (1980) . This somewhat pragmatic approach to nomenclature has also been applied to other pathogenic bacteria species, such as those of the genus Brucella. However, Savin et al. have failed to prove that the pathogenicity or the life cycle of the 'Korean group' is so divergent that the generation of a novel species can be justified.
In summary, we argue that the previous classification used for this group of organisms is the better one -that the 'Korean Group' of Y. pseudotuberculosis should continue to be classified as a named subgroup in the species Y. pseudotuberculosis, not as the separate species Y. wautersii as proposed by Savin et al. (2014a) . However, we agree that this and other matters of classification will be decided by the scientific community as reflected by usage, particularly in the literature.
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